[2024] FWC 2351
General information, not legal advice.
Fair Work Commission
2024-09-02
Original judgment source is linked above.
The attached document replaces the document previously issued with the above code on 2 September 2024.
s.394 - Application for unfair dismissal remedy
Application for an unfair dismissal remedy - applicant failed drug test - applicant did not disclose prescribed medicinal cannabis - breach of policy - valid reason - dismissal not unfair - application dismissed
Mr Gauci's role and his employment with DP World
Mr Gauci's medical condition and use of medicinal cannabis
Dosage: Initial dose: 0.25mL BD SL (daily); increase each dose by 0.1ml every two days if required until symptoms are controlled, or side effects occur; Maximum daily dose: 3.0mL
Dosage: Initial dose: 0.1g via vape PRN; increase by 0.1g every two days if required until symptoms are controlled, or side effects occur; Maximum daily dose: 1.0g
Dosage: Initial dose: 0.1g via vape PRN; increase by 0.1g every two days if required until symptoms are controlled, or side effects occur; Maximum daily dose: 1.0g.
"I will be drug and alcohol free at work and advise of any injuries, medications or medical conditions that could impede my ability to do my job safely before I commence work".
"FAIR WORK COMMISSION CONFIRMS THAT DP WORLD POLICY SHOULD BE COMPLIED WITH BY EMPLOYEES
DP World is committed to providing a safe work environment, and our Alcohol and other Drugs Policy clearly set out that employees may not use either alcohol or illicit drugs and attend the workplace. Doing so places you and your workmates at an unacceptable risk.
DP World terminated the employment of a long serving employee, from the Fishermans Island terminal who tested non-negative to THC (cannabis). He elected to challenge this in the Fair Work Commission who upheld DP World's decision to terminate his employment. The case has highlighted a number of key findings which are important to share:
Firstly, the work being performed by employees at our Terminals, whether it be as a Stevedore, on a vessel or in the Control Room, is safety critical and that DP World's zero tolerance stance is proportional and required.
Secondly, there is no safe 'window of detection' and that certain drugs can stay in your system for days, weeks or months. This means there is no means by which an employee can be confident there are no drugs in their system when they attend for work.
Thirdly, attending for work with drugs in their system shows reckless indifferent to breaching the policy.
This decision is an important reminder for all workers to follow the Policy at all times.
Our Policy is based on the "presence" of a drug rather than "impairment". This means DP World does not need to prove that your work or performance has been adversely affected by the drugs- the presence of the substance is the breach.
The employee has decided to appeal this decision. DP World will continue to defend its zero tolerance approach to managing drugs and alcohol in the workplace.
We all share a responsibility for maintaining a safe working environment DP World has a zero tolerance to drugs and alcohol in the workplace. Its simply not worth the risk to yourself or others.
Any employee who returns a non-negative reading will be stood down and subject to a show cause process. With disciplinary action, up to and including termination."
Was there a valid reason for the dismissal related to the Applicant's capacity or conduct (including its effect on the safety and welfare of other employees)?
a) failing to declare that he had been prescribed and was using medicinal cannabis; and
b) attending for work with an elevated level of a proscribed substance in his system.
"[f]or that reason, employer policies which provide for disciplinary action
including dismissal where an employee tests positive for
cannabis simpliciter may, at least in the context of safety-critical work,
be adjudged to be lawful and reasonable."[68]
Was Mr Gauci aware of his obligations under the policy?
Should reasonably have led him to seek clarification of these points prior to commencing consumption.
"Nothing can be more important than protecting health and safety in the workplace, and a drug and alcohol policy is one important means of doing so. Failure to comply with a reasonable workplace drug and alcohol policy is unacceptable, first and foremost because it undermines efforts to keep workers safe, and secondly because it exposes the employer to risk."[80]
Was the Applicant notified of the valid reason?
Was the Applicant given an opportunity to respond to any valid reason related to their capacity or conduct?
" ...the opportunity to defend, implies an opportunity that might result in the employer deciding not to terminate the employment if the defence is of substance. An employer may simply go through the motions of giving the employee an opportunity to deal with allegations concerning conduct when, in substance, a firm decision to terminate had already been made which would be adhered to irrespective of anything the employee might say in his or her defence. That, in my opinion, does not constitute an opportunity to defend_._"
Did the Respondent unreasonably refuse to allow the Applicant to have a support person present to assist at discussions relating to the dismissal?
Was the Applicant warned about unsatisfactory performance before the dismissal?
To what degree would the size of the Respondent's enterprise be likely to impact on the procedures followed in effecting the dismissal?
To what degree would the absence of dedicated human resource management specialists or expertise in the Respondent's enterprise be likely to impact on the procedures followed in effecting the dismissal?
Summary dismissal was disproportionate - Other appropriate sanctions

[1] P.17 of the DCB - Termination Letter.
[2] P.459 of the DCB - Letter from Dr Joshua Gabriel.
[3] P.50 of the DCB - Witness Statement of Michael Gauci at 46.
[9] P.50 of the DCB - Witness Statement of Michael Gauci at 12.
[14] P.690 of the DCB - Confirmatory Result.
[15] P.12 of the DCB - Show Cause Letter.
[17] P.743 of the DCB - Witness Statement of Benjamin Hanley at 22 to 23.
[23] P.48 of the DCB - Witness Statement of Michael Gauci at 32 & P.455 of the DCB - Patient Consent Form.
[24] P.745 of the DCB - Witness Statement of Benjamin Hanley at 28.
[25] P.15 to 17 of the DCB - Termination Letter.
[26] P.741 of the DCB - Witness Statement of Benjamin Hanley at 13.
[29] P.876 of the DCB - Alcohol and Other Drugs Policy at Appendix B.
[30] P.781 of the DCB - Code of Conduct.
[31] P.742 of the DCB - Witness Statement of Benjamin Hanley at 17.
[33] P.851 of the DCB - Bulletin of Policy Update.
[36] P.815 of the DCB - Bulleting regarding Prescription Medicine Declarations.
[37] P.902 of the DCB - Policy Circular.
[38] P.89 of the DCB - DP World Brisbane Enterprise Agreement 2020 & P.473 of the DCB - DP World Alcohol and Other Drugs Policy.
[39] P.516 of the DCB - Expert Report of Dr Michael Robertson.
[46] P.965 of the DCB - Expert Report of Dr Michelle Williams.
[52] P.545 of the DCB - Reply Witness Statement of Michael Gauci.
[53] Fair Work Act 2009 (Cth) s.382.
[54] Raj Bista v Group Pty Ltd t/a Glad Commercial Cleaning [2016] FWC 3009
[55] Selvachandran v Peteron Plastics Pty Ltd [1995] IRCA 333; (1995) 62 IR 371, 373.
[57] [2021] FWC 4 at 118.
[58] Commonwealth of Australia (Australian Taxation Office) t/a Australian Taxation Office v Shamir [2016] FWCFB 4185, [46] citing Allied Express Transport Pty Ltd v Anderson (1998) 81 IR 410, 413.
[59] P.35 of the DCB - Applicant Submissions.
[65] P.729 of the DCB - Respondent Submissions.
[66] B, C and D v Australian Postal Corporation [2013] FWCFB 6191; (2013) 238 IR 1 at [36].
[67] P.731 of the DCB - Respondent Submissions.
[69] P.730 of the DCB - Respondent Submissions.
[71] Sharp v BCS Infrastructure Support Pty Limited [2015] FWCFB 1033 at [26]- [27].
[72] P.731 & 732 of the DCB - Respondent Submissions.
[73] P.742 of the DCB - Witness Statement of Benjamin Hanley at 13.
[74] P.965 of the DCB - Expert Report of Dr Michelle Williams.
[75] P.472 of the DCB - DP World Alcohol and Other Drugs Policy.
[76] P.40 of the DCB - Applicant Submissions at 32.
[80] Mr Jake Candido v Scalzo Food Industries [2024] FWC 2129 at [11]
[81] P.37 of the DCB - Applicant Submissions at 16 & P.732 of the DCB - Respondent Submissions at 33.
[82] P.37 of the DCB - Applicant Submissions at 17
[85] [2010] FWA 8544 at [85].
[86] P.733 of the DCB - Respondent Submissions at 35.
[87] P.733 of the DCB - Respondent Submissions at 37.
[88] P.38 of the DCB - Applicant Submissions at 20.
[89] P.733 of the DCB - Respondent Submissions at 38.
[90] P.38 of the DCB - Applicant Submissions at 21.
[91] P.733 of the DCB - Respondent Submissions at 38.
[92] Harbour City Ferries Pty Ltd v Toms [2014] FWCFB 6249 at (25].
[93] P.41 of the DCB - Applicant Submissions at 35 to 37.
[94] P.747 of the DCB - Witness Statement of Benjamin Hanley at 34.
Printed by authority of the Commonwealth Government Printer
Michael Gauci
DP World Brisbane Pty Limited [2024] FWC 2351
(1995) 62 IR 371
(1998) 81 IR 410
(2013) 238 IR 1